A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study
Clinical trial NCT03875092 · COMPLETED
Trial details
- NCT number
- NCT03875092
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-21
- Primary completion
- 2020-09-30
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.